- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00465036
Effect of Flaxseed on Lipid Uptake and Appetite
March 25, 2009 updated by: University of Copenhagen
Effect of Whole Flaxseeds and Flaxseed Mucilage on Lipid Absorption, Glucose and Insulin Metabolism and Appetite Regulation
Randomized trial to test the effect of flaxseed fractions on appetite regulation and intestinal lipid absorption.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Randomized multiple crossover trial in 18 healthy males aged 18 to 40 years each are required to complete a total of five iso-caloric meal tests lasting approximately 8½ hours.
Test meals will be given as breakfast meals, in which different fractions of flaxseeds are incorporated into baked products.
Appetite will be registered using visual analogue scales during 7 hours after the test meal and a total of 10 blood samples will be drawn to evaluate TAG in chylomicrons, plasma LDL, HDL and total cholesterol, plasma TAG, insulin, glucose and appetite hormone levels.
At the end of the test day an ad libitum meal will be served and food intake registered.
Study Type
Interventional
Enrollment
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Frederiksberg C, Denmark, 1958
- Institute of Human Nutrition
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Healthy males aged 18-40 years
- Normal weight or moderately overweigh (BMI 25-30 kg/m2)
Exclusion Criteria:
- Blood drawing/donation less than six months prior to start of the study
- Hemoglobin concentration <8mmol/L
- Chronic diseases (i.e. diabetes, CVD), hypertension, hyperlipidemia
- Consumption of dietary supplements including vitamin tablets
- Smoking
- Excess physical activity (>10h of intense physical activity per week)
- Medicine use (not including occasional consumption of pain killers)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
TAG in chylomicrons
|
|
serum TAG
|
|
HDL, LDL and total cholesterol
|
|
appetite scores
|
|
ad libium food intake
|
|
appetite hormone levels
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
free fatty acid profile
|
|
plasma glucose
|
|
plasma insulin
|
|
meal macronutrient composition
|
|
meal energy content
|
|
meal pleasantness
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Søren Toubro, MD, Institute of Human Nutrition
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2006
Study Completion (ACTUAL)
October 1, 2007
Study Registration Dates
First Submitted
April 23, 2007
First Submitted That Met QC Criteria
April 23, 2007
First Posted (ESTIMATE)
April 24, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
March 26, 2009
Last Update Submitted That Met QC Criteria
March 25, 2009
Last Verified
March 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KF 01 309595
- B226
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.